Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
US Army
Daiichi Sankyo
AstraZeneca
Covington
Argus Health
Fish and Richardson
Cantor Fitzgerald

Generated: July 18, 2018

DrugPatentWatch Database Preview

NITROGLYCERIN IN DEXTROSE 5% Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Nitroglycerin In Dextrose 5% patents expire, and what generic alternatives are available?

Nitroglycerin In Dextrose 5% is a drug marketed by Baxter Hlthcare and Hospira and is included in five NDAs.

The generic ingredient in NITROGLYCERIN IN DEXTROSE 5% is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.
Summary for NITROGLYCERIN IN DEXTROSE 5%
Drug patent expirations by year for NITROGLYCERIN IN DEXTROSE 5%
Pharmacology for NITROGLYCERIN IN DEXTROSE 5%
Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Medical Subject Heading (MeSH) Categories for NITROGLYCERIN IN DEXTROSE 5%

US Patents and Regulatory Information for NITROGLYCERIN IN DEXTROSE 5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 019970-001 Dec 29, 1989 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 071848-001 Aug 31, 1990 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 074083-001 Oct 26, 1994 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare NITROGLYCERIN IN DEXTROSE 5% nitroglycerin INJECTABLE;INJECTION 019970-002 Dec 29, 1989 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Merck
Deloitte
Daiichi Sankyo
Express Scripts
Fish and Richardson
AstraZeneca
Chinese Patent Office
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.